Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Regulus slides after hep C contender's results underwhelm investors
Regulus slides after hep C contender's results underwhelm investors
Regulus slides after hep C contender's results underwhelm investors
Submitted by
admin
on February 9, 2015 - 8:30am
Source:
Fierce Biotech
News Tags:
Regulus
hepatitis C
RG-101
microRNA
Headline:
Regulus slides after hep C contender's results underwhelm investors
Do Not Allow Advertisers to Use My Personal information
